[
  {
    "ts": null,
    "headline": "REGN Robbins Geller Rudman & Dowd LLP Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
    "summary": "The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. securities between November 2, 2023 and October 30, 2024, both dates...",
    "url": "https://finnhub.io/api/news?id=2f3aec6db86b9947bc36a88b47b7abbe0278de734be3b3084d397de5f3f420cd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736544663,
      "headline": "REGN Robbins Geller Rudman & Dowd LLP Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
      "id": 132375373,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. securities between November 2, 2023 and October 30, 2024, both dates...",
      "url": "https://finnhub.io/api/news?id=2f3aec6db86b9947bc36a88b47b7abbe0278de734be3b3084d397de5f3f420cd"
    }
  },
  {
    "ts": null,
    "headline": "Why Regeneron (REGN) is Poised to Beat Earnings Estimates Again",
    "summary": "Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=35327f1250e487cc1c6a0776e93fc2e89fd0c95f0c2a867f902e856c8677b61e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736529015,
      "headline": "Why Regeneron (REGN) is Poised to Beat Earnings Estimates Again",
      "id": 132371629,
      "image": "https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=35327f1250e487cc1c6a0776e93fc2e89fd0c95f0c2a867f902e856c8677b61e"
    }
  },
  {
    "ts": null,
    "headline": "Law Offices of Howard G. Smith Encourages Regeneron Pharmaceuticals, Inc. (REGN) Investors To Inquire About Securities Fraud Class Action",
    "summary": "Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Regeneron Pharmaceuticals, Inc. securities between November 2, 2023 and...",
    "url": "https://finnhub.io/api/news?id=a41c563be70ae086a172e47ff3df8f237a9f9f4bba95abd507ad081fd1c9bdd8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736520603,
      "headline": "Law Offices of Howard G. Smith Encourages Regeneron Pharmaceuticals, Inc. (REGN) Investors To Inquire About Securities Fraud Class Action",
      "id": 132368948,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Regeneron Pharmaceuticals, Inc. securities between November 2, 2023 and...",
      "url": "https://finnhub.io/api/news?id=a41c563be70ae086a172e47ff3df8f237a9f9f4bba95abd507ad081fd1c9bdd8"
    }
  },
  {
    "ts": null,
    "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=3fcadff8204f640836845b06147d8e9955a054e410f500e732d88155104116e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736517614,
      "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
      "id": 132369270,
      "image": "https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=3fcadff8204f640836845b06147d8e9955a054e410f500e732d88155104116e0"
    }
  },
  {
    "ts": null,
    "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, Jan. 10, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ...",
    "url": "https://finnhub.io/api/news?id=fd338add5c91146c22bfab6e66d180693fd1d93a3d1b30420b00101bace6afff",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736472784,
      "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 132357380,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "LOS ANGELES, Jan. 10, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ...",
      "url": "https://finnhub.io/api/news?id=fd338add5c91146c22bfab6e66d180693fd1d93a3d1b30420b00101bace6afff"
    }
  }
]